HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoqian Liu Selected Research

CXC 195

1/2014Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats.
1/2013Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion injury in the rat by an antioxidant action via inhibition of NADPH oxidase and iNOS expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoqian Liu Research Topics

Disease

10Neoplasms (Cancer)
08/2022 - 11/2009
10Glioma (Gliomas)
01/2020 - 04/2009
6Inflammation (Inflammations)
07/2022 - 07/2010
5Infections
01/2022 - 01/2017
5Infarction (Infarctions)
01/2021 - 06/2011
5Brain Ischemia (Cerebral Ischemia)
01/2015 - 06/2011
4Wounds and Injuries (Trauma)
01/2020 - 12/2017
4Reperfusion Injury
01/2015 - 06/2011
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2015 - 06/2011
3Obesity
01/2022 - 01/2021
3Osteoarthritis
01/2021 - 12/2019
3Ischemia
12/2017 - 01/2013
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2017 - 01/2016
3Multiple Sclerosis
10/2017 - 01/2016
2Carcinoma (Carcinomatosis)
09/2022 - 01/2012
2Knee Osteoarthritis
11/2021 - 12/2019
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 01/2012
2Stroke (Strokes)
01/2021 - 01/2015
2Pain (Aches)
01/2021 - 02/2018
2Joint Diseases (Joint Disease)
01/2020 - 01/2017
2Lupus Nephritis
01/2012 - 07/2010
2Hyperplasia
01/2012 - 01/2012
1Adenocarcinoma
09/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2022
1Lymphoma (Lymphomas)
08/2022
1Ulcer
07/2022
1Stomach Ulcer (Gastric Ulcer)
07/2022
1Hyperuricemia
04/2022
1Non-alcoholic Fatty Liver Disease
01/2022
1Hallucinations (Hallucination)
01/2022
1Coccidiosis
12/2021
1Heat Stroke (Heatstroke)
12/2021
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
11/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2021
1Body Weight (Weight, Body)
03/2021
1Insulin Resistance
03/2021
1Coronary Disease (Coronary Heart Disease)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Chronic Disease (Chronic Diseases)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
08/2022 - 06/2009
6CytokinesIBA
07/2022 - 01/2015
5Small Interfering RNA (siRNA)IBA
10/2019 - 12/2014
4Biomarkers (Surrogate Marker)IBA
12/2021 - 05/2016
4Pharmaceutical PreparationsIBA
12/2019 - 11/2009
3FlavonoidsIBA
07/2022 - 01/2022
3AntigensIBA
12/2021 - 03/2016
3Neuroprotective AgentsIBA
01/2021 - 06/2011
3AntioxidantsIBA
01/2021 - 01/2013
3Glucose (Dextrose)FDA LinkGeneric
01/2020 - 11/2012
3StathminIBA
12/2014 - 03/2012
3Interleukin-18 (Interleukin 18)IBA
01/2012 - 07/2010
2Biological ProductsIBA
09/2022 - 07/2016
2Ethanol (Ethyl Alcohol)IBA
07/2022 - 06/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2022 - 11/2009
2Interleukin-6 (Interleukin 6)IBA
04/2022 - 01/2015
2LipidsIBA
01/2022 - 01/2013
2Carrier Proteins (Binding Protein)IBA
09/2021 - 07/2010
2Blood Glucose (Blood Sugar)IBA
01/2021 - 01/2020
2NF-kappa B (NF-kB)IBA
01/2021 - 11/2009
2Peptides (Polypeptides)IBA
01/2020 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 03/2010
2RNA (Ribonucleic Acid)IBA
06/2018 - 09/2015
2Carnitine (L-Carnitine)FDA LinkGeneric
02/2018 - 12/2017
2CateninsIBA
05/2016 - 01/2012
2MicroRNAs (MicroRNA)IBA
05/2016 - 12/2013
2Messenger RNA (mRNA)IBA
07/2015 - 01/2012
2NADPH Oxidases (NAD(P)H oxidase)IBA
01/2015 - 01/2013
2CXC 195IBA
01/2014 - 01/2013
2tetramethylpyrazineIBA
01/2014 - 01/2013
1Protein Isoforms (Isoforms)IBA
08/2022
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
08/2022
1Oncogene Proteins (Oncogene Protein)IBA
08/2022
1AcidsIBA
07/2022
1Hydrochloric Acid (Hydrogen Chloride)FDA Link
07/2022
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
04/2022
1IridoidsIBA
04/2022
1FructoseIBA
04/2022
1Uric Acid (Urate)IBA
04/2022
1Toll-Like Receptor 4IBA
04/2022
1GTP-Binding Proteins (G-Protein)IBA
01/2022
1DNA VaccinesIBA
12/2021
1Subunit VaccinesIBA
12/2021
1FlagellinIBA
12/2021
1ChlorophyllIBA
09/2021
1Adenosine Triphosphate (ATP)IBA
09/2021
1Photosystem II Protein Complex (Photosystem II)IBA
09/2021
1EnzymesIBA
09/2021
1Chlorophyll AIBA
09/2021
1Chimeric Antigen ReceptorsIBA
07/2021
1acacetinIBA
03/2021
1Neuraminidase (Sialidase)IBA
03/2021
1Rituximab (Mabthera)FDA Link
01/2021
1Prednisone (Sone)FDA LinkGeneric
01/2021

Therapy/Procedure

6Therapeutics
04/2022 - 11/2009
3Drug Therapy (Chemotherapy)
01/2019 - 11/2009
2Aftercare (After-Treatment)
01/2021 - 12/2017
2Radiotherapy
09/2015 - 12/2014
1Injections
11/2021
1Hematopoietic Stem Cell Transplantation
11/2021